Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Empire State Of Mind: Lilly Aims To Build Academic Ties With N.Y. Research Center

Executive Summary

Eli Lilly & Co. gained a foothold in New York with its acquisition of ImClone Systems Inc. in 2008. Now it's looking to make more of a splash in the city and strengthen ties with local academic powerhouses by taking up residence in a new state-of-the-art biotech facility.
Advertisement

Related Content

Back To School: Big Pharmas Test New Models For Tapping Academia
Back To School: Big Pharmas Test New Models For Tapping Academia
Pfizer Signs Up Seven New York Institutions To Create Biomedical Discovery Engine
Pfizer Signs Up Seven New York Institutions To Create Biomedical Discovery Engine
Avid Amyvid Could Be Approved If Training Improves, Advisory Committee Says
GSK's "Biotech-In-A-Pharma" R&D Model Makes Progress
Lilly Continues To Bet On Alzheimer's With Avid Acquisition
Reenergizing R&D: Sanofi Stirs The Pot, But Does It Have The Recipe?
Lilly Closes Its Singapore Drug Discovery Center; Is China Discovery Unit In The Works?
Lilly Plays Up R&D Productivity With Reorganization

Topics

Advertisement
UsernamePublicRestriction

Register

PS053074

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel